Cancer Genomics: Researching New Treatment Strategies to Cure Infant Acute Lymphoblastic Leukemia (ALL)
Files
Download Transcript, Episode 69 (79 KB)
Loading...
Document Type
Podcast
Hosts
Michael Smith
Featured Speaker
Erin Guest, MD
Length of Episode
14:13
Description
Only about 100 infants are diagnosed with acute lymphoblastic leukemia (ALL) in the U.S. each year. Most of these babies respond to chemotherapy treatment at first, but go on to relapse and die of the disease.
Dr. Erin Guest and colleagues at Children’s Mercy are performing genomics research to uncover the reasons why leukemia in infants becomes resistant to treatment. Dr. Guest is also leading a national clinical trial for infants with ALL, through the Children’s Oncology Group.
Listen in as Erin Guest, MD discusses how she is working with researchers from around the globe to design new treatment strategies that will cure more infants with leukemia.
Publication Date
10-16-2016
Recommended Citation
Smith, Michael and Guest, Erin M., "Cancer Genomics: Researching New Treatment Strategies to Cure Infant Acute Lymphoblastic Leukemia (ALL)" (2016). Transformational Pediatrics Podcast. 69.
https://scholarlyexchange.childrensmercy.org/transformational-peds_podcast/69
